Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain - PubMed (original) (raw)
Comparative Study
doi: 10.1086/425589. Epub 2004 Sep 27.
Barbara K Lipska, Nader Halim, Quang D Ma, Mitsuyuki Matsumoto, Samer Melhem, Bhaskar S Kolachana, Thomas M Hyde, Mary M Herman, Jose Apud, Michael F Egan, Joel E Kleinman, Daniel R Weinberger
Affiliations
- PMID: 15457404
- PMCID: PMC1182110
- DOI: 10.1086/425589
Comparative Study
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain
Jingshan Chen et al. Am J Hum Genet. 2004 Nov.
Erratum in
- Am J Hum Genet. 2005 Jun;76(6):1089
Abstract
Catechol-O-methyltransferase (COMT) is a key enzyme in the elimination of dopamine in the prefrontal cortex of the human brain. Genetic variation in the COMT gene (MIM 116790) has been associated with altered prefrontal cortex function and higher risk for schizophrenia, but the specific alleles and their functional implications have been controversial. We analyzed the effects of several single-nucleotide polymorphisms (SNPs) within COMT on mRNA expression levels (using reverse-transcriptase polymerase chain reaction analysis), protein levels (using Western blot analysis), and enzyme activity (using catechol methylation) in a large sample (n = 108) of postmortem human prefrontal cortex tissue, which predominantly expresses the -membrane-bound isoform. A common coding SNP, Val158Met (rs4680), significantly affected protein abundance and enzyme activity but not mRNA expression levels, suggesting that differences in protein integrity account for the difference in enzyme activity between alleles. A SNP in intron 1 (rs737865) and a SNP in the 3' flanking region (rs165599)--both of which have been reported to contribute to allelic expression differences and to be associated with schizophrenia as part of a haplotype with Val--had no effect on mRNA expression levels, protein immunoreactivity, or enzyme activity. In lymphocytes from 47 subjects, we confirmed a similar effect on enzyme activity in samples with the Val/Met genotype but no effect in samples with the intron 1 or 3' SNPs. Separate analyses revealed that the subject's sex, as well as the presence of a SNP in the P2 promoter region (rs2097603), had small effects on COMT enzyme activity. Using site-directed mutagenesis of mouse COMT cDNA, followed by in vitro translation, we found that the conversion of Leu at the homologous position into Met or Val progressively and significantly diminished enzyme activity. Thus, although we cannot exclude a more complex genetic basis for functional effects of COMT, Val is a predominant factor that determines higher COMT activity in the prefrontal cortex, which presumably leads to lower synaptic dopamine levels and relatively deleterious prefrontal function.
Figures
Figure 1
Effect of the Val/Met SNP on S-COMT and MB-COMT protein immunoreactivity. A, Comparison of protein immunoreactivity (analyzed by Western blotting with the use of a specific anti-human COMT antibody) for S-COMT and MB-COMT proteins in postmortem DLPFC tissues with genotypes Val/Val, Val/Met, and Met/Met. The asterisk (*) indicates difference from Val/Val at a significance level of
P<.05
. B, A representative Western blotting image with MB-COMT, S-COMT, and internal control (Actin) bands.
Figure 2
Significantly higher activity of COMT-Val than of COMT-Met in human DLPFC tissue and in lymphocytes at 37°C. A, High correlation of the relative COMT activity with protein concentration (
_r_=0.999
) in a linear relationship. B, COMT activity in protein samples from human postmortem DLPFC tissues with genotypes Val/Val, Val/Met, and Met/Met. C, COMT activity in protein samples from lymphoblast cultures from subjects with genotypes Val/Val and Met/Met. N = sample size. Two asterisks (**) indicate difference from Val/Val at a significance level of
P<.01
.
Figure 3
Effect of the Val/Met genotype on COMT activity in human postmortem DLPFC tissue from two different populations (African Americans and whites). The effects of the Val/Met genotype in African Americans (A) and whites (B) were similar. N = sample size. One asterisk (*) indicates difference from Val/Val at a significance level of
P<.05
; two asterisks (**) indicate difference from Val/Val at a significance level of
P<.001
.
Figure 4
Comparison of the ratio of the enzyme activity between the heat-treated and cold-treated MB-COMT-Met and MB-COMT-Val. MB-COMT-Val is more stable than MB-COMT-Met at 37°C. The ratios (± SE) of COMT activity in the synthesized MB-COMT-Val and MB-COMT-Met samples exposed to a temperature of 37°C for 0–120 min (H) or kept on ice at 4°C (C), measured in triplicate. One asterisk (*) indicates difference from COMT-Met at a significance level of
P<.05
; two asterisks (**) indicate difference from MB-COMT-Met at a significance level of
P<.01
.
Figure 5
Comparison of the human and mouse cDNA sequences and COMT activity from three assays. The activity of mouse COMT-Leu is higher than that of human COMT-Val and COMT-Met. S-COMT proteins from human COMT-Val and COMT-Met, as well as mouse COMT-Leu, were synthesized using an in vitro transcription-coupled transcription system with 35S-methionine as a radioactive substrate. A, Representative autoradiogram of the synthesized proteins with radioactive 35S-methionine residue and the amino acid sequences of the three COMT proteins. B, Averaged COMT activity from three independent assays, normalized with the radioactivity of the 35S-labeled COMT proteins. The activity of mouse COMT-Leu is significantly higher than that of human COMT-Val or COMT-Met. Two asterisks (**) indicate difference from mouse COMT-Leu at a significance level of
P<.0001
.
Figure 6
Comparison of the activity of the proteins in mouse COMT-Leu, COMT-Met, and COMT-Val. Mutations from Leu to Val and Met in mouse COMT resulted in a dramatic reduction in COMT activity. The Leu codon in mouse COMT cDNA was mutated into Val or Met by site-directed mutagenesis, and the wild-type and mutant mouse COMT proteins were synthesized using an in vitro protein synthesis system. A, Representative autoradiogram of the wild-type and mutant mouse S-COMT proteins labeled with 35S-methionine and partial protein sequences. B, Averaged COMT activity from three independent assays, normalized with COMT protein levels. COMT activity differs significantly between the wild-type and mutant proteins. Two asterisks (**) indicate difference from wild-type COMT-Leu at a significance level of
P<.0001
.
Figure 7
Effect of the P2 promoter SNP on COMT activity in human DLPFC (A) and lymphoblast cell cultures (B) of different genotypes at the promoter SNP site. Two asterisks (**) indicate difference from genotype 1/1 at a significance level of
P<.01
. Similar effects were seen in lymphocytes of subjects with the homozygous Met/Met genotype. C, Abundant MB-COMT protein, detected by Western blotting with the use of a specific anti-human COMT antibody, in lymphocytes (L) and brain (B) protein samples.
Figure 8
Effect of the subject's sex on COMT activity in human DLPFC. Females had significantly lower COMT activity in the samples as a whole (A) as well as in each of the Val/Met genotypes (B). The asterisk (*) indicates difference from males at a significance level of
P<.05
.
Similar articles
- Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia.
Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen J, Hyde TM, Herman MM, Weinberger DR, Kleinman JE. Matsumoto M, et al. Neuropsychopharmacology. 2003 Aug;28(8):1521-30. doi: 10.1038/sj.npp.1300218. Epub 2003 Jun 11. Neuropsychopharmacology. 2003. PMID: 12799619 - Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortex.
Parkin GM, Udawela M, Gibbons A, Scarr E, Dean B. Parkin GM, et al. J Hum Genet. 2018 Dec;63(12):1251-1258. doi: 10.1038/s10038-018-0511-2. Epub 2018 Sep 14. J Hum Genet. 2018. PMID: 30218069 - RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
Lipska BK, Mitkus S, Caruso M, Hyde TM, Chen J, Vakkalanka R, Straub RE, Weinberger DR, Kleinman JE. Lipska BK, et al. Hum Mol Genet. 2006 Sep 15;15(18):2804-12. doi: 10.1093/hmg/ddl222. Epub 2006 Aug 11. Hum Mol Genet. 2006. PMID: 16905560 - Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
Apud JA, Weinberger DR. Apud JA, et al. CNS Drugs. 2007;21(7):535-57. doi: 10.2165/00023210-200721070-00002. CNS Drugs. 2007. PMID: 17579498 Review. - [Association and its forensic significance between COMT gene and schizophrenia].
Ding CL, Zhou X, Wang BJ, Ding M, Pang H. Ding CL, et al. Fa Yi Xue Za Zhi. 2012 Aug;28(4):299-304. Fa Yi Xue Za Zhi. 2012. PMID: 23033671 Review. Chinese.
Cited by
- The relationship between COMT, proline, and negative symptoms in clinical high risk and recent psychosis onset.
Clelland JD, Hesson H, Ramiah K, Anderson J, Thengampallil A, Girgis RR, Clelland CL. Clelland JD, et al. Transl Psychiatry. 2024 Oct 2;14(1):409. doi: 10.1038/s41398-024-03099-0. Transl Psychiatry. 2024. PMID: 39358340 Free PMC article. - A dopaminergic basis of behavioral control.
Ballard IC, Furman DJ, Berry AS, White RL 3rd, Jagust WJ, Kayser AS, D'Esposito M. Ballard IC, et al. bioRxiv [Preprint]. 2024 Oct 2:2024.09.17.613524. doi: 10.1101/2024.09.17.613524. bioRxiv. 2024. PMID: 39345422 Free PMC article. Preprint. - The Neurocomputational Mechanism Underlying Decision-Making on Unfairness to Self and Others.
Luo L, Xu H, Tian X, Zhao Y, Xiong R, Dong H, Li X, Wang Y, Luo YJ, Feng C. Luo L, et al. Neurosci Bull. 2024 Oct;40(10):1471-1488. doi: 10.1007/s12264-024-01245-8. Epub 2024 Jun 20. Neurosci Bull. 2024. PMID: 38900383 - Interaction between catechol-O-methyltransferase Val/Met polymorphism and cognitive reserve for negative symptoms in schizophrenia.
Hou WP, Qin XQ, Hou WW, Han YY, Bo QJ, Dong F, Zhou FC, Li XB, Wang CY. Hou WP, et al. World J Psychiatry. 2024 May 19;14(5):695-703. doi: 10.5498/wjp.v14.i5.695. eCollection 2024 May 19. World J Psychiatry. 2024. PMID: 38808087 Free PMC article. - Association between executive functions and COMT Val108/158Met polymorphism among healthy younger and older adults: A preliminary study.
Apa Z, Gilsoul J, Dideberg V, Collette F. Apa Z, et al. PLoS One. 2024 May 13;19(5):e0303343. doi: 10.1371/journal.pone.0303343. eCollection 2024. PLoS One. 2024. PMID: 38739620 Free PMC article.
References
Electronic-Database Information
- Mammalian Gene Collection, http://mgc.nci.nih.gov/
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for the COMT gene)
- Software and Course Materials, http://www-gene.cimr.cam.ac.uk/clayton/software/
References
- Ahsan H, Chen Y, Whittemore AS, Kibriya MG, Gurvich I, Senie RT, Santella RM (2004) A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 85:121–131 - PubMed
- Ailenberg M, Silverman M (1997) Site-directed mutagenesis using a PCR-based staggered re-annealing method without restriction enzymes. Biotechniques 22:624–626, 628, 630 - PubMed
- Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702–705 - PubMed
- Badner JA, Gershon ES (2002) Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7:405–411 - PubMed
- Boudikova B, Szumlanski C, Maidak B, Weinshilboum R (1990) Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48:381–389 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous